甘氨酸
Search documents
“冠军”的背后|福华化学荣获国家“制造业单项冠军企业”称号
Jin Rong Jie· 2026-02-12 14:46
来源:川观新闻 对于乐山企业,这是一项荣誉,更是一针强心剂。 近日,工业和信息化部"制造业单项冠军企业(2025—2027年)"名单公布,福华通达化学股份公司(以 下简称"福华")位列其中。 "制造业单项冠军企业"代表着国内制造业细分领域的最高发展水平和最强市场实力,被誉为"中国制造 体系的金字塔尖"。 为何这家来自乐山五通桥的企业能获此殊荣,对于乐山又带来什么启示? 冠军的炼成 千年盐文化,乐山五通桥。从制盐到盐化工,五通桥这座千年古城见证着盐业文明与工业经济的交汇。 福华便生于斯、长于斯。 2007年,公司成立;2016年起,便连续数年位列世界农化20强——核心产品草甘膦原药2018获评国家 级"单项冠军产品",产能稳居全球前三,原粉出口量连续7年位居国内首位;离子膜烧碱、甘氨酸等关 键产品产能领跑中国西南地区。 从"冠军产品"到"冠军企业",福华靠的是什么?带着这样的疑问,我们走进公司。 走进厂区,映入眼帘的是一汪清澈的池塘。这是公司的生态监测池,池内锦鲤自在游弋。废水养鱼,窥 见的是一篇绿色循环文章。 草甘膦可以有效控制杂草生长,提高作物产量质量。但另一方面,草甘膦生产过程中产生的母液则是一 种高有机 ...
石油与化工指数多数上涨(1月5日至9日)
Zhong Guo Hua Gong Bao· 2026-01-13 03:30
Group 1: Chemical Sector Performance - The chemical index outperformed the oil index last week, with all chemical indices rising. The chemical raw materials index increased by 5.14%, the chemical machinery index rose by 7.20%, the chemical pharmaceuticals index climbed by 7.33%, and the pesticide and fertilizer index went up by 5.10% [1] - In the oil sector, the oil processing index increased by 0.65%, while the oil extraction index fell by 3.82%, and the oil trading index rose by 4.88% [1] Group 2: Oil Price Movements - International crude oil prices showed mixed trends. As of January 9, the settlement price for West Texas Intermediate (WTI) crude oil was $59.12 per barrel, up 3.14% from January 2. The settlement price for Brent crude oil was $63.34 per barrel, up 4.26% from January 2 [1] Group 3: Petrochemical Product Price Changes - The top five petrochemical products with the highest price increases were battery-grade lithium carbonate (up 18.21%), butadiene (up 10.37%), isooctyl acrylate (up 8.23%), diethylene glycol (up 5.90%), and polybutadiene rubber (up 4.86%). The top five products with the largest price declines were liquid chlorine (down 31.25%), glycine (down 4.55%), vitamin D3 (down 4.00%), mancozeb (down 3.45%), and acrylonitrile (down 3.33%) [1] Group 4: Capital Market Performance of Listed Chemical Companies - The top five listed chemical companies with the highest stock price increases were Puli Tech (up 42.59%), Dawi Technology (up 35.34%), Sanfu Co. (up 32.29%), Guofeng Plastics (up 30.63%), and Tongcheng New Materials (up 30.54%). The bottom five companies with the largest stock price declines were Evergrande High-tech (down 13.05%), Jiabiyou (down 12.16%), Hangzhou High-tech (down 11.24%), Yahua Group (down 6.59%), and Fengshen Co. (down 5.48%) [2]
江山股份(600389) - 江山股份2025年三季度主要经营数据公告
2025-10-27 08:30
证券代码:600389 证券简称:江山股份 公告编号:临 2025-053 主要产品 2025 年 1-9 月产量 (吨) 2025 年 1-9 月销量 (吨) 2025 年 1-9 月销 售金额(万元) 除草剂产品 69,186.61 77,570.04 203,389.99 杀虫剂产品 18,147.73 20,846.32 55,354.20 氯碱产品 700,266.70 470,554.83 42,082.32 阻燃剂(磷系) 产品 45,280.33 50,604.57 37,999.77 一、主要产品的产量、销量及收入实现情况 主要产品 2025 年 1-9 月平 均售价(元/吨) 2024 年 1-9 月平 均售价(元/吨) 同期变动 比率(%) 第二季度环比 变动比率(%) 除草剂产品 26,220.17 30,010.43 -12.63 6.93 杀虫剂产品 26,553.46 27,147.14 -2.19 -0.62 氯碱产品 894.31 893.18 0.13 -3.69 二、主要产品的价格变动情况(不含税) 南通江山农药化工股份有限公司 2025 年三季度主要经营数据公告 本公司 ...
江山股份(600389) - 江山股份2025年半年度主要经营数据公告
2025-08-25 12:38
南通江山农药化工股份有限公司 2025 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露:第十三 号—化工》、《关于做好主板上市公司 2025 年半年度报告披露工作的重要提醒》 的要求,南通江山农药化工股份有限公司(以下简称"公司")现将 2025 年半年 度主要经营数据披露如下: 注 1:上述产量含自用量、农药按含量折原药计算(下同)。 注 2:除草剂产品包括草甘膦、酰胺类等产品;杀虫剂产品包括敌百虫、敌敌畏、二嗪 磷等产品;氯碱产品包括烧碱、盐酸、液氯、次氯酸钠等产品,其中烧碱产销量 按 32%、48%烧碱实物量计算(下同)。 证券代码:600389 证券简称:江山股份 公告编号:临 2025-044 注 3:阻燃剂(磷系)产品包含 TCPP、BDP 产品(下同)。 | 主要产品 | 2025 | 年 | 1-6 月平 | 2024 月平 | 年 | 1-6 | 同期变动 | 第二季度环比 | | --- | --- | --- | - ...
和邦生物:公司计划在四川广安建设50万吨/年双甘膦产品生产线,没有投产50万吨甘氨酸的计划
Mei Ri Jing Ji Xin Wen· 2025-08-15 11:21
Group 1 - The company plans to construct a production line for 500,000 tons per year of glyphosate in Guang'an, Sichuan [2] - There are no plans to produce 500,000 tons of glycine [2] - The company advises that significant operational information should be referenced in official announcements [2]
新琪安拟港交所上市,年营收5.69亿,王小强家族掌舵引关注
Sou Hu Cai Jing· 2025-05-29 06:12
Core Viewpoint - New Qian has successfully passed the Hong Kong Stock Exchange listing hearing and is preparing to enter the capital market, marking a new chapter for the company in the food additives sector [1] Financial Performance - New Qian's revenue fluctuated over the past few years, with 2022 revenue at 761.5 million RMB, dropping to 446.9 million RMB in 2023, and recovering to 568.9 million RMB in 2024 [2] - Gross profit also experienced similar volatility, decreasing from 194.9 million RMB in 2022 to 79.9 million RMB in 2023, then rising to 101.9 million RMB in 2024 [2] - The company's net profit declined from 122 million RMB in 2021 to 44.7 million RMB in 2022, further decreasing to 43.4 million RMB in 2023, although adjusted net profit in 2023 showed a recovery to 53.6 million RMB [2] Cash Position and Dividend Policy - New Qian's cash and cash equivalents have been decreasing over the past three years, reaching 46.1 million RMB as of December 31, 2024 [3] - The company has been conservative in dividend distribution, declaring a mid-term dividend of approximately 8.6 million RMB in 2022, a final dividend of about 11.1 million RMB in 2023, and no dividends in 2024 [3] Corporate Governance - The company's governance structure exhibits a strong family influence, with key positions held by family members of Chairman Wang Xiaoqiang, including his son and spouse [3] - The shareholding structure reflects this family influence, with Wang Xiaoqiang holding 6.9% and New Qian Industrial holding 41.1%, collectively controlling 59.8% of the company [6] Shareholding Structure - Major shareholders include institutional investors such as Guo Xin Hong Sheng (9.8%), Fu Xing Investment (6%), and Xing Zheng Strategic Entrepreneurship (5.7%), which contribute to the company's capital vitality [6]
北元集团: 华泰联合证券有限责任公司关于陕西北元化工集团股份有限公司调整募集资金投资项目实施进度的核查意见
Zheng Quan Zhi Xing· 2025-05-28 10:39
Summary of Key Points Core Viewpoint - The company, Shaanxi Beiyuan Chemical Group Co., Ltd., has decided to adjust the implementation schedule of its fundraising investment projects due to objective factors such as macroeconomic conditions and industry cycle fluctuations, while ensuring that the project content, investment total, and scale remain unchanged [1][11][12]. Group 1: Fundraising Overview - The company approved the public offering of up to 361,111,112 new shares, with total fundraising amounting to 343,999.07 million yuan [1][2]. - As of December 31, 2024, the actual use of the raised funds is 102,829.73 million yuan [4][10]. Group 2: Project Delay Details - The completion dates for several projects, including the 120,000 tons/year glycine project and the intelligent factory basic platform construction, have been extended to June 2025 due to various delays [6][10]. - The company plans to further adjust the completion dates for several projects to June 2027, including the 100,000 tons/year CPE and 20,000 tons/year CPVC projects [6][10]. Group 3: Reasons for Delay - The glycine project is delayed due to the immature industrial production setup of the mixed solvent method and the need for further testing and equipment selection [7][10]. - The intelligent factory project is affected by the need for system optimization and compliance with safety standards [8][10]. - The salt production project faces market challenges due to limited demand and economic viability [9][10]. Group 4: Measures to Ensure Completion - The company is actively working on plans to utilize by-products from the glycine project and is optimizing project management to ensure timely completion [7][8]. - Detailed optimization plans and strategies are being developed to ensure the intelligent factory project progresses smoothly [8][10]. - The company is conducting thorough market analysis and technical research to validate the feasibility of the salt production project [9][10]. Group 5: Impact of Project Delay - The delay in fundraising investment projects is based on careful consideration of objective circumstances and does not involve changes to project implementation subjects, fundraising purposes, or investment scales, thus not adversely affecting the company's operations or shareholder interests [10][11].
北元集团: 陕西北元化工集团股份有限公司第三届监事会第七次会议决议公告
Zheng Quan Zhi Xing· 2025-05-28 10:17
Group 1 - The company held its seventh meeting of the third supervisory board, which complied with legal and regulatory requirements [1] - The supervisory board unanimously agreed to abolish the supervisory board and transfer its powers to the audit committee, with amendments to the company's articles of association to take effect upon approval by the shareholders' meeting [1] - The voting results showed 10 votes in favor, 0 against, and 0 abstentions [1] Group 2 - The company agreed to adjust the completion dates for several fundraising investment projects, including the 120,000 tons/year glycine project and the smart factory infrastructure project, to June 2027 [2] - The supervisory board confirmed that the adjustments do not constitute a disguised change in the use of raised funds and are in the best interest of the company and all shareholders [2] - The voting results for this decision were also 10 votes in favor, 0 against, and 0 abstentions [2] Group 3 - The supervisory board approved the continued use of idle raised funds for cash management, allowing for investment in safe and liquid financial products up to RMB 2.6 billion [3] - This decision aims to enhance the efficiency of fund utilization without affecting the construction of fundraising projects [3] - The investment products include structured deposits, time deposits, and agreement deposits, with individual investment terms not exceeding 12 months [3]
新安股份(600596) - 新安股份2024年度主要经营数据公告
2025-04-29 14:31
证券代码: 600596 证券简称:新安股份 公告编号:2025-028 号 浙江新安化工集团股份有限公司 2024 年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露:第十三 号—化工》有关规定和披露要求,浙江新安化工集团股份有限公司(以下简称"公 司")现将 2024 年度主要经营数据披露如下: | 主要产品 | 2024 年 1-12 月生 产量(吨) | 2024 年 1-12 月销 售量(吨) | 2024 年 1-12 月销售金 额(万元) | | --- | --- | --- | --- | | 农化原药 | 105,000.67 | 23,092.34 | 77,438.23 | | 农化制剂 | 214,784.72 | 200,825.03 | 337,441.13 | | 环体硅氧烷 | 195,835.99 | 111,989.87 | 146,756.74 | | 硅氧烷中间体 | 106,858.27 | 63 ...
江山股份(600389) - 江山股份2025年第一季度主要经营数据公告
2025-04-21 13:14
证券代码:600389 证券简称:江山股份 公告编号:临 2025-022 南通江山农药化工股份有限公司 2025 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露:第十三 号—化工》、《关于做好主板上市公司 2025 年第一季度报告披露工作的重要提醒》 的要求,南通江山农药化工股份有限公司(以下简称"公司")现将 2025 年第一 季度主要经营数据披露如下: 注 1:上述产量含自用量、农药按含量折原药计算(下同)。 | 主要原料 | 2025 年 1-3 月平 均进价(元/吨) | 2024 | 年 1-3 月平 均进价(元/吨) | 同期变动 比率(%) | 第一季度 环比变动 比率(%) | | --- | --- | --- | --- | --- | --- | | 甘氨酸 | 9,368.58 | | 9,532.20 | -1.72 | -4.04 | | 双甘膦 | 12,479.92 | | 12,831.86 | -2 ...